Examiner: DARPOLOR, JOSEPHINE KEBBEH

Tech Center 1600 • Art Units: 1642 1671

This examiner grants 64% of resolved cases

Performance Statistics

64.5%

Allow Rate

+4.5% vs TC avg

Total Applications

+37.9%

Interview Lift

1292

Avg Prosecution Days

Based on 31 resolved cases, 2023–2026

2.2%

§101 Eligibility

15.1%

§102 Novelty

33.0%

§103 Obviousness

31.3%

§112 Clarity

App #	Title	Status	Assignee
17931396	Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) Inhibitors	Non-Final OA	Regeneron Pharmaceuticals, Inc.
17997244	ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF	Non-Final OA	Board of Regents, The University of Texas System

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.